IMBIQ — Legacy IMBDS Income Statement
0.000.00%
- $0.00m
- $169.59m
- $544.56m
- 35
- 92
- 17
- 46
Annual income statement for Legacy IMBDS, fiscal year end - January 28th, USD millions except per share, conversion factor applied.
2019 February 2nd | 2020 February 1st | 2021 January 30th | 2022 January 29th | 2023 January 28th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 597 | 502 | 454 | 551 | 545 |
| Cost of Revenue | |||||
| Gross Profit | 207 | 164 | 167 | 223 | 210 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 615 | 554 | 462 | 563 | 592 |
| Operating Profit | -18.6 | -52.5 | -7.94 | -11.4 | -47.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -22.1 | -56.3 | -13.2 | -22.9 | -70.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -22.2 | -56.3 | -13.2 | -23 | -70.5 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -22.2 | -56.3 | -13.2 | -22 | -70 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -22.2 | -56.3 | -13.2 | -22 | -70 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.06 | -5.92 | -1.12 | -0.838 | -1.9 |